By Ayo Onikoyi

Dr. Tolulope Ojo-Akosile, a distinguished researcher, is at the forefront of pioneering studies into infectious diseases and cancer.

Emphasising the pressing need to deepen our comprehension of these health challenges, Dr. Ojo-Akosile’s diverse research initiatives span from HIV and Hansen’s disease to anal, cervical, and ovarian cancers.

In collaboration with the Winship Cancer Institute and Rollins School of Public Health, Dr. Ojo-Akosile’s team is actively generating crucial preliminary data concerning invasive ovarian cancer.

Their focus lies on tracking changes in body compositions, circulating inflammatory biomarkers, and tumor immune markers from pre-treatment to post-treatment stages.

By delving into the complex interplay between patient demographics, lifestyle factors, and cancer survival rates, their study aims to illuminate the underlying causes of ovarian cancers while offering hope to affected individuals.

Dr. Ojo-Akosile’s extensive portfolio also encompasses research on the co-infection of HIV and HPV and its correlation with HPV-related cancers.

Through her work with marginalised populations, particularly individuals living with HIV and precancerous conditions, she provides vital support to prevent cancer progression and facilitates access to treatment.

Additionally, her involvement in a NIH-funded grant focusing on cervical cancer screening in Nigeria underscores her commitment to global health equity.

In her role as Assistant Director of Programs at Emory University School of Medicine, Dr. Ojo-Akosile spearheads strategic planning and implementation for the Community Outreach and Engagement component of the Emory Hansen’s Disease Program and the National Hansen’s Disease Program.

Actively engaging with diverse stakeholders, she fosters partnerships with community organizations, healthcare systems, and governmental agencies to address the impact of Hansen’s disease on affected populations.

Among her ongoing endeavors is a research study investigating the prevalence of asymptomatic Hansen’s Disease or previous exposure in household members of diagnosed patients.

By measuring anti-PGL-1 antibodies in blood samples, this study aims to enhance our understanding of Hansen’s Disease transmission dynamics within the United States, paving the way for targeted interventions and prevention strategies.

Dr. Tolulope Ojo-Akosile’s multifaceted research and leadership exemplify a commitment to advancing scientific knowledge and promoting health equity in the face of complex health challenges.